๐ฒ๐ฏ๐ถ๐ด๐ฎ-๐ฉ๐๐ฆ๐๐ข๐ก stands for ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ฐ๐ฒ-๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ถ๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป ๐ณ๐ผ๐ฟ ๐ด๐ผ๐ผ๐ฑ ๐๐ถ๐๐ถ๐ผ๐ป ๐ฎ๐ ๐ฎ๐ป๐ ๐ฎ๐ด๐ฒ โ a science-driven approach to supporting visual health across all stages of life. Founded in 2010 and based in Greifswald, Germany, the company combines ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ฒ๐
๐ฝ๐ฒ๐ฟ๐๐ถ๐๐ฒ with a clear focus on ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต, ๐พ๐๐ฎ๐น๐ถ๐๐, ๐ฎ๐ป๐ฑ ๐๐ฟ๐ฎ๐ป๐๐ฝ๐ฎ๐ฟ๐ฒ๐ป๐ฐ๐.
๐ฉ๐ถ๐๐ถ๐ผ๐ป:
The potential of targeted micronutrition in eye care remains far from being fully realized. Our aim is to enable eye care professionals and patients to rely on the ๐ฝ๐ฟ๐ผ๐๐ฒ๐ป ๐ฏ๐ฒ๐ป๐ฒ๐ณ๐ถ๐๐ ๐ผ๐ณ ๐๐ฎ๐ฟ๐ด๐ฒ๐๐ฒ๐ฑ ๐บ๐ถ๐ฐ๐ฟ๐ผ๐ป๐๐๐ฟ๐ถ๐ฒ๐ป๐ ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐.
This is why ๐๐ฟ๐๐๐ โ ๐ฏ๐๐ถ๐น๐ ๐ผ๐ป ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ฐ๐ฒ ๐ฎ๐ป๐ฑ ๐๐ป๐ฐ๐ผ๐บ๐ฝ๐ฟ๐ผ๐บ๐ถ๐๐ถ๐ป๐ด ๐พ๐๐ฎ๐น๐ถ๐๐ โ is at the heart of everything we do.
๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฎ๐ป๐ฑ ๐๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป
The efficacy of ๐ฉ๐ถ๐๐ฟ๐ผ๐๐ฎ๐ฝยฎ๐ก ๐ณ๐ผ๐ฟ ๐๐ถ๐๐ฟ๐ฒ๐ผ๐๐ ๐ณ๐น๐ผ๐ฎ๐๐ฒ๐ฟ๐ has been demonstrated in five clinical studies, including the prospective, double-blind ๐๐น๐ผ๐ฎ๐๐ฒ๐ฟ ๐๐ป๐๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐ผ๐ป ๐ฆ๐๐๐ฑ๐ (๐๐๐๐๐ฆ).
Three studies confirm the positive effect of the micronutrient composition in ๐ฅ๐ฒ๐๐ถ๐๐ฎ๐ฝยฎ๐๐ฅ on contrast sensitivity, retinal sensitivity, visual acuity, and retinal thickness in patients with diabetes.
Our ๐บ๐ฎ๐ฐ๐๐น๐ฎ๐ฟ ๐บ๐ถ๐ฐ๐ฟ๐ผ๐ป๐๐๐ฟ๐ถ๐ฒ๐ป๐๐ (such as ๐ ๐ฎ๐ฐ๐๐๐ฎ๐ฝยฎ๐๐ ๐) are strictly aligned with current guidelines on micronutrient therapy, as established by the ๐๐ฅ๐๐๐ฆ/๐๐ฅ๐๐๐ฆ2 studies. Our product development also incorporates recent findings from ๐๐ฅ๐๐ฆ๐ง and ๐ ๐ข๐ฆ๐ง, highlighting the benefits of ๐บ๐ฒ๐๐ผ-๐๐ฒ๐ฎ๐
๐ฎ๐ป๐๐ต๐ถ๐ป as the third macular carotenoid.
To ensure scientific relevance and innovation, ๐ฒ๐ฏ๐ถ๐ด๐ฎ-๐ฉ๐๐ฆ๐๐ข๐ก maintains active collaboration and exchange with the ophthalmic research and clinical community. We also contribute to knowledge transfer by hosting our own symposia at major international congresses.
